Suzanne Oparil

发表

Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women

Constance K Haan, Patrick McBride, Anne L. Taylor, 2004, Circulation.

David A Calhoun, S. Oparil, D. Calhoun, 2003, Annals of Internal Medicine.

Treatment of Hypertension in Patients With Coronary Artery Disease: A Scientific Statement From the American Heart Association, American College of Cardiology, and American Society of Hypertension

Christopher M O'Connor, Christopher P Cannon, Matthew Allison, 2015, Hypertension.

Stroke Reduction in Hypertensive Adults With Cardiac Hypertrophy Randomized to Losartan Versus Atenolol: The Losartan Intervention For Endpoint Reduction in Hypertension Study

Katherine E. Harris, Richard B. Devereux, Hans Wedel, 2005, Hypertension.

Hypoxia-responsive growth factors upregulate periostin and osteopontin expression via distinct signaling pathways in rat pulmonary arterial smooth muscle cells.

Peng Li, S. Oparil, Peng Li, 2004, Journal of applied physiology.

Fibroblast Growth Factor Receptor-1 Signaling Induces Osteopontin Expression and Vascular Smooth Muscle Cell–Dependent Adventitial Fibroblast Migration In Vitro

S. Oparil, Guohong Li, John A Thompson, 2002, Circulation.

Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update.

Rowena J Dolor, Constance K Haan, Diana Petitti, 2007, Journal of the American College of Cardiology.

Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial

Neil Chapman, Manish Saxena, Jai Radhakrishnan, 2018, The Lancet.

The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: The Systolic Blood Pressure Intervention Trial (SPRINT)

Walter T Ambrosius, Anthony A Killeen, Jackson T. Wright, 2014, Clinical trials.

When and how to use self (home) and ambulatory blood pressure monitoring.

Thomas G Pickering, William B White, Suzanne Oparil, 2010, Journal of the American Society of Hypertension : JASH.

Effect of Chlorthalidone, Amlodipine, and Lisinopril on Visit‐to‐Visit Variability of Blood Pressure: Results From the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial

Barry R Davis, B. Davis, P. Whelton, 2014, Journal of clinical hypertension.

Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association.

Rowena J Dolor, Dong Zhao, Theresa M Beckie, 2011, Journal of the American College of Cardiology.

Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women

Constance K Haan, Patrick McBride, Anne L. Taylor, 2004, Arteriosclerosis, thrombosis, and vascular biology.

Evidence-based guidelines for cardiovascular disease prevention in women.

Constance K Haan, Patrick McBride, Anne L. Taylor, 2004, Circulation.

Pulse wave velocity and central aortic pressure in systolic blood pressure intervention trial participants

Walter T Ambrosius, Laura Lovato, Jeffrey Bates, 2018, PloS one.

Evidence-Based Guideline for the Management of High Blood Pressure in Adults

Jackson T. Wright, S. Oparil, W. Cushman, 2012 .

Rationale and Design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Michael A. Proschan, Barry R. Davis, Curt D. Furberg, 1996 .

Treatment of Hypertension in the Prevention and Management of Ischemic Heart Disease: A Scientific Statement From the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention

Bernard J. Gersh, Henry R. Black, Christopher M. O’Connor, 2007, Circulation.

Treatment of Hypertension in Patients With Coronary Artery Disease: A Scientific Statement From the American Heart Association, American College of Cardiology, and American Society of Hypertension

Christopher M O'Connor, Christopher P Cannon, Matthew Allison, 2015 .

Effects of Pressure Overload on Extracellular Matrix Expression in the Heart of the Atrial Natriuretic Peptide–Null Mouse

Dajun Wang, S. Oparil, S. John, 2003, Hypertension.

Drugs targeting the renin–angiotensin–aldosterone system

David A. Calhoun, S. Oparil, D. Calhoun, 2002, Nature Reviews Drug Discovery.

Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial.

Lenore J Launer, Virginia G Wadley, J. Williamson, 2016, JAMA.

Visit-to-Visit Variability of Blood Pressure and Coronary Heart Disease, Stroke, Heart Failure, and Mortality

Barry R. Davis, B. Davis, P. Whelton, 2015, Annals of Internal Medicine.

Notice

David C. Wheeler, Susan L. Furth, Carmine Zoccali, 2012, Kidney International Supplements.

Obesity-Associated Hypertension: the Upcoming Phenotype in African-American Women

Abhishek Jaiswal, S. Oparil, Suzanne Oparil, 2017, Current Hypertension Reports.

Treatment of Hypertension in Patients With Coronary Artery Disease: A Scientific Statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension.

Christopher M O'Connor, Christopher P Cannon, Matthew Allison, 2015, Journal of the American College of Cardiology.

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

Steven Snapinn, Ulf de Faire, Richard B Devereux, 2002, The Lancet.

Catheter‐Based Renal Denervation for Resistant Hypertension: Rationale and Design of the SYMPLICITY HTN‐3 Trial

Deepak L. Bhatt, Murray Esler, S. Oparil, 2012, Clinical cardiology.

Major clinical trials of hypertension: what should be done next?

Thomas D. Giles, Eric Boerwinkle, John B. Kostis, 2005, Hypertension.

Low sodium intake--cardiovascular health benefit or risk?

S. Oparil, Suzanne Oparil, 2014, The New England journal of medicine.